The LEN4PrEP study: protocol for a phase 3B, non-randomised clinical trial integrating lenacapavir PrEP within multi-product HIV prevention services in primary care clinics in South Africa. (link.springer.com)

Authors: Drysdale RE … Mullick S Journal: BMC Infectious Diseases Published: 2026-07-23 DOI: https://doi.org/10.1186/s12879-026-14082-z